{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:41:01Z","timestamp":1773294061298,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.eplepsyres.2016.03.004","type":"journal-article","created":{"date-parts":[[2016,3,15]],"date-time":"2016-03-15T22:32:08Z","timestamp":1458081128000},"page":"110-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Weight gain in children on oxcarbazepine monotherapy"],"prefix":"10.1016","volume":"122","author":[{"given":"Anastasia","family":"Garoufi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Vartzelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charalambos","family":"Tsentidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achilleas","family":"Attilakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelia","family":"Koemtzidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia","family":"Kossiva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eustathia","family":"Katsarou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Soldatou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2-3","key":"10.1016\/j.eplepsyres.2016.03.004_bib0005","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.eplepsyres.2006.06.015","article-title":"Early effect of sodium valproate and Carbamazepine monotherapy on homocysteine metabolism in children with epilepsy","volume":"71","author":"Attilakos","year":"2006","journal-title":"Epilepsy Res."},{"issue":"8","key":"10.1016\/j.eplepsyres.2016.03.004_bib0010","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2165\/00148581-200305080-00006","article-title":"Oxcarbazepine a review of its use in children with epilepsy","volume":"5","author":"Bang","year":"2003","journal-title":"Pediatr. Drugs"},{"issue":"6","key":"10.1016\/j.eplepsyres.2016.03.004_bib0015","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ejpn.2011.05.004","article-title":"Serum insulin, cortisol, leptin, neuropeptide Y, galanin and ghrelin levels in epileptic children receiving oxcarbazepine","volume":"15","author":"Cansu","year":"2011","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"1","key":"10.1016\/j.eplepsyres.2016.03.004_bib0020","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000327367","article-title":"S Serum insulin, cortisol, leptin, neuropeptide Y, galanin and ghrelin levels in epileptic children receiving valproate","volume":"76","author":"Cansu","year":"2011","journal-title":"Horm. Res. Paediatr.;"},{"issue":"4","key":"10.1016\/j.eplepsyres.2016.03.004_bib0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/07435800.2012.662663","article-title":"The effects of oxcarbazepine and valproate therapies on growth in children with epilepsy","volume":"37","author":"Cansu","year":"2012","journal-title":"Endocr. Res."},{"issue":"1","key":"10.1016\/j.eplepsyres.2016.03.004_bib0030","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1528-1167.2011.03316.x","article-title":"Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis","volume":"53","author":"Chuang","year":"2012","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.eplepsyres.2016.03.004_bib0035","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2165\/00148581-200810040-00003","article-title":"Use of second-generation antiepileptic drugs in the pediatric population","volume":"10","author":"Chung","year":"2008","journal-title":"Pediatr. Drugs"},{"issue":"7244","key":"10.1016\/j.eplepsyres.2016.03.004_bib0040","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1136\/bmj.320.7244.1240","article-title":"Establishing a standard definition for child overweight and obesity worldwide: international survey","volume":"320","author":"Cole","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.eplepsyres.2016.03.004_bib0045","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1528-1167.2010.02522.x","article-title":"Terminology of the international league against epilepsy (2010) Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE commission on classification and terminology, 2005\u20132009","volume":"51","author":"Commission on Classification and","year":"2010","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.eplepsyres.2016.03.004_bib0050","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ejpn.2010.02.004","article-title":"Growth hormone levels in children and adolescents with epilepsy","volume":"14","author":"El-Khayat","year":"2010","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"2","key":"10.1016\/j.eplepsyres.2016.03.004_bib0055","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.seizure.2012.11.007","article-title":"Assessment of atherosclerosis risk due to the homocysteine-asymmetric dimethylarginine-nitric oxide cascade in children taking antiepileptic drugs","volume":"22","author":"Emerksiz","year":"2013","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2016.03.004_bib0060","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/j.1468-1331.2006.01535.x","article-title":"Preliminary report on effects of oxcarbazepine-treatment on serum lipid levels in children","volume":"13","author":"Franzoni","year":"2006","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.eplepsyres.2016.03.004_bib0065","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/ene.12262","article-title":"Lipid profile and thyroid hormone concentrations in children with epilepsy treated with oxcarbazepine monotherapy: a prospective long-term study","volume":"21","author":"Garoufi","year":"2014","journal-title":"Eur. J. Neurol."},{"issue":"2\u20133","key":"10.1016\/j.eplepsyres.2016.03.004_bib0070","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.eplepsyres.2007.03.010","article-title":"Vascular risk factors and oxidative stress as independent predictors of asymptomatic atherosclerosis in adult patients with epilepsy","volume":"74","author":"Hamed","year":"2007","journal-title":"Epilepsy Res."},{"issue":"3","key":"10.1016\/j.eplepsyres.2016.03.004_bib0075","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejpn.2008.05.005","article-title":"States of serum leptin and insulin in children with epilepsy: risk predictors of weight gain","volume":"13","author":"Hamed","year":"2009","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"1","key":"10.1016\/j.eplepsyres.2016.03.004_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2007.04.001","article-title":"Leptin and insulin homeostasis in epilepsy: relation to weight adverse conditions","volume":"75","author":"Hamed","year":"2007","journal-title":"Epilepsy Res."},{"issue":"1","key":"10.1016\/j.eplepsyres.2016.03.004_bib0085","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1586\/17512433.2015.991716","article-title":"Antiepileptic drugs influences on body weight in people with epilepsy","volume":"8","author":"Hamed","year":"2015","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2016.03.004_bib0090","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1734-1140(09)70082-9","article-title":"Atherosclerotic risk among children taking antiepileptic drugs","volume":"61","author":"Jakubus","year":"2009","journal-title":"Pharmacol. Rep."},{"issue":"10","key":"10.1016\/j.eplepsyres.2016.03.004_bib0095","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1111\/epi.12338","article-title":"Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy","volume":"54","author":"Kim","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2016.03.004_bib0100","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1515\/JPEM.2011.309","article-title":"Obesity and associated cardiovascular risk factors among schoolchildren in Greece: a cross-sectional study and review of the literature","volume":"24","author":"Kollias","year":"2011","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.eplepsyres.2016.03.004_bib0105","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1517\/14740338.6.3.251","article-title":"The adverse effects of antiepileptic drugs in children","volume":"6","author":"Kothare","year":"2007","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.eplepsyres.2016.03.004_bib0110","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/1471-2431-13-211","article-title":"The impact of the use of antiepileptic drugs on the growth of children","volume":"13","author":"Lee","year":"2013","journal-title":"BMC Pediatr."},{"issue":"7","key":"10.1016\/j.eplepsyres.2016.03.004_bib0115","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/j.1528-1167.2005.34304.x","article-title":"Growth and lipid metabolism in girls and young women with epilepsy during pubertal maturation","volume":"46","author":"Mikkonen","year":"2005","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.eplepsyres.2016.03.004_bib0120","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.pediatrneurol.2005.08.032","article-title":"Central hypothyroidism with oxcarbazepine therapy","volume":"34","author":"Miller","year":"2006","journal-title":"Pediatr. Neurol."},{"issue":"S3","key":"10.1016\/j.eplepsyres.2016.03.004_bib0125","first-page":"1","article-title":"Weight change by oxcarbazepine monotherapy in childhood epilepsy","volume":"47","author":"Nam","year":"2006","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.eplepsyres.2016.03.004_bib0130","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1212\/01.WNL.0000048209.07526.86","article-title":"Fasting serum insulin and lipid levels in men with epilepsy","volume":"60","author":"Pylv\u00e4nen","year":"2003","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.eplepsyres.2016.03.004_bib0135","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1542\/peds.103.3.588","article-title":"The effects of valproate, carbamazepine, and oxcarbazepine on growth and sexual maturation in gilrls with epilepsy","volume":"103","author":"R\u00e4tty\u00e4","year":"1999","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.eplepsyres.2016.03.004_bib0140","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1469-8749.2009.03402.x","article-title":"Chronic antiepileptic monotherapy, bone metabolism, and body composition in non-institutionalized children","volume":"52","author":"Rauchenzauner","year":"2010","journal-title":"Dev. Med. Child Neurol."},{"issue":"1","key":"10.1016\/j.eplepsyres.2016.03.004_bib0145","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/08830738060210011301","article-title":"Effect of antiepileptic drugs on plasma lipids, lipoprotein (a), and liver enzymes","volume":"21","author":"Sonmez","year":"2006","journal-title":"J. Child Neurol."},{"issue":"7","key":"10.1016\/j.eplepsyres.2016.03.004_bib0150","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00381-012-1788-7","article-title":"Plasma leptin, neuropeptide Y, ghrelin, and adiponectin levels and carotid artery intima media thickness in epileptic children treated with valproate","volume":"28","author":"Tokgoz","year":"2012","journal-title":"Childs Nerv. Syst."},{"issue":"3","key":"10.1016\/j.eplepsyres.2016.03.004_bib0155","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.0013-9580.2004.26003.x","article-title":"Thyroid function in girls with epilepsy with Carbamazepine, oxcarbazepine, or valproate monotherapy and after withdrawal of medication","volume":"45","author":"Vainionp\u00e4\u00e4","year":"2004","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.eplepsyres.2016.03.004_bib0160","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1528-1167.2009.02206.x","article-title":"The metabolic syndrome in overweight epileptic patients treated with valproic acid","volume":"51","author":"Verrotti","year":"2010","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.eplepsyres.2016.03.004_bib0165","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1111\/j.1467-789X.2010.00800.x","article-title":"Weight gain following treatment with valproic acid: pathogenetic mechanisms and clinical implications","volume":"12","author":"Verrotti","year":"2011","journal-title":"Obes. Rev."},{"issue":"2-3","key":"10.1016\/j.eplepsyres.2016.03.004_bib0170","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.eplepsyres.2006.05.002","article-title":"Early and persistent increase in serum lipoprotein (a) concentration in epileptic children treated with Carbamazepine and sodium valproate monotherapy","volume":"70","author":"Voudris","year":"2006","journal-title":"Epilepsy Res."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121116300365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121116300365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:35:27Z","timestamp":1760276127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121116300365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":34,"alternative-id":["S0920121116300365"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2016.03.004","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Weight gain in children on oxcarbazepine monotherapy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2016.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}